braf-mutant melanoma: frontline decisions
Published 7 years ago • 617 plays • Length 6:08Download video MP4
Download video MP3
Similar videos
-
6:08
braf-mutant melanoma: frontline decisions
-
8:13
case 2: frontline decisions in stage iv braf-mutant melanoma
-
7:01
dual-targeted therapy for braf-mutant melanoma
-
1:42
dr. flaherty on second-line therapy for braf-mutant melanoma
-
9:49
melanoma: nuances of braf/mek combinations in the front line
-
7:15
dual targeted or immunotherapy for braf-mutant melanoma
-
6:39
questions about sequencing in braf-mutant melanoma
-
10:08
emerging approaches for braf-mutant metastatic melanoma
-
6:33
treatment of braf-mutant metastatic melanoma
-
27:28
advances in therapy for braf-mutant melanoma
-
1:17
treatment selection for stage iii braf-mutant melanoma
-
1:32
dr. pavlick on sequencing challenges with braf-mutant melanoma
-
1:32
dr. flaherty on the rationale to explore triplet therapy in braf v600e-mutant melanoma
-
1:36
dr. weber on combination strategies for braf-mutant melanoma
-
1:22
dr. polsky on validating ctdna as a biomarker in braf-mutant melanoma
-
1:52
dr. long on dabrafenib/trametinib in braf v600e-mutant melanoma
-
1:09
dr. atkinson discusses braf-mutant metastatic melanoma
-
6:12
braf as a driver in melanoma
-
1:06
dr. ryan sullivan on treating braf-mutant patients with melanoma